2023年7月11日

搜索工作11 - 2023年7月需求增加體外膜肺氧合(ECMO)機器市場穩定增長到2032年的5%的複合年增長率:改變在危重病醫學技術的不斷發展格局,體外膜肺氧合機市場已成為一個革命性的工具在急救護理。這些生命維持設備提供臨時呼吸和/或心髒支持患者嚴重的肺或心髒衰竭。ECMO機作為外部肺或心髒,補氧的血液和除去二氧化碳,使病人的器官休息和治療。全球醫學界的機器市場正在經曆顯著的增長,推動技術的進步,提高意識,和不斷上升的呼吸和心髒疾病的發病率。最初主要用於兒科病例,醫學界機器正在使用在所有年齡組,包括新生兒、兒童和成人。此外,他們的應用程序擴展超出了心髒和呼吸支持包括ECMO-assisted器官移植手術和治療急性呼吸窘迫綜合征(ARDS), COVID-19-related呼吸衰竭和傷害引起肺損傷。今天讓你複製:揭示體外膜肺氧合機市場的巨大的市場潛力——下載樣本報告現在@ https://www.futuremarketinsights.com/reports/sample/rep - gb - 14300體外膜肺氧合機市場價值為5.31億美元,2021年預計將穩步上升,從2022年到2032年的複合年增長率為5%,年底達到9080億美元。ECMO機市場已經目睹了近年來大幅增長,預計將繼續快速擴張。造成這種增長的因素包括呼吸和心髒疾病的患病率增加,日益老齡化,高級生命支持係統的不斷增長的需求。此外,正在進行的研究和開發工作ECMO技術預計將進一步增強其功能和燃料市場的增長。 Key Takeaways: By application, high demand for early diagnosis and diagnostic imaging, and technological advancements in the extracorporeal membrane oxygenation machine market are expected to propel the respiratory segment to the top. The arterio-venous segment is likely to hold the majority of the market based on modality owing to the benefits associated with this technology segment, such as effective dynamic range, thereby boosting the ECMO systems market growth. Based on patient type, the adult segment is projected to lead the market as the global burden of cardiac and respiratory diseases in adults is rising due to increased consumption of alcohol, tobacco, smoking, and a sedentary lifestyle. Feel free to reach out to our analyst for any queries you might have @ https://www.futuremarketinsights.com/ask-question/rep-gb-14300 North American market is anticipated to be at the forefront of the ECMO systems market because of the presence of key players and the rising number of product launches, government support for high-quality healthcare which is also considered to be a few crucial ECMO systems market trends and the rising prevalence of diseases in the United States and Canada, such as chronic obstructive pulmonary disease resulting in increased hospital admission favoured by reimbursement policies, is expected to boost the sales of ECMO systems in this region. asserts an FMI analyst. Competitive Landscape: Companies like Abbott Laboratories, Medtronic, Alung Technologies, and Terumo Corporation dominate the global market. Major global players produce the majority of ECMO support systems. Market leaders have established their position by investing more in research and having a better distribution system. To stay competitive in the market, extracorporeal membrane oxygenation machines manufacturers are actively involved in product launches and technological innovation. ALung Technologies, Inc. has begun commercialization of its ground-breaking next-generation artificial lung. The device is based on University of Pittsburgh intellectual property licensed to ALung Technologies, Inc. Medtronic has released its artificial lung therapy for the treatment of COVID-19. An artificial pump that pumps blood from a person’s body to an oxygenator is called ECMO, and it also has an FDA-approved device for ECMO procedures lasting up to 6 hours. Customize Your Knowledge: Unlock Targeted Insights to Drive Growth in the Extracorporeal Membrane Oxygenation Machine Market @ https://www.futuremarketinsights.com/customization-available/rep-gb-14300 Key Segments By Product: